Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain
Bruna Panizzutti, Chiara C. Bortolasci, Briana Spolding, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4095-4095
Open Access | Times Cited: 12

Showing 12 citing articles:

Psychiatric Disorders and Obesity in Childhood and Adolescence—A Systematic Review of Cross-Sectional Studies
Ioulia Kokka, Iraklis Mourikis, Flora Bacopoulou
Children (2023) Vol. 10, Iss. 2, pp. 285-285
Open Access | Times Cited: 33
Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review
Lizeth Sepúlveda-Lizcano, Vivian Vanessa Arenas-Villamizar, Enna Beatriz Jaimes-Duarte, et al.
European Journal of Investigation in Health Psychology and Education (2023) Vol. 13, Iss. 8, pp. 1505-1520
Open Access | Times Cited: 24
Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
Tzu‐Hua Wu, Shu-Chin Hu, Nailis Sylfa, et al.
Journal of Psychopharmacology (2025)
Closed Access
Effect of antipsychotics on the focal adhesion pathway
Bruna Panizzutti, Chiara C. Bortolasci, Briana Spolding, et al.
The World Journal of Biological Psychiatry (2025), pp. 1-7
Open Access
Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models.
Robert A. Kozol, Julia E. Dallman
F1000Research (2023) Vol. 12, pp. 84-84
Open Access | Times Cited: 3
Research progress in the correlation between SREBP/PCSK9 pathway and lipid metabolism disorders induced by antipsychotics.
Jiashu Ma, Yunshao Zheng, Fengxia Sun, et al.
PubMed (2023) Vol. 48, Iss. 10, pp. 1529-1538
Closed Access | Times Cited: 2
Psychotropic medicines: increased appetite rather than weight gain
Leonardo Tondo, Ross J. Baldessarini
The Lancet Psychiatry (2022) Vol. 9, Iss. 2, pp. e8-e8
Open Access | Times Cited: 3
Glucose and Lipid Profiles Predict Anthropometric Changes in Drug-Naïve Adolescents Starting Treatment with Risperidone or Sertraline: A Pilot Study
Emilia Matera, Gloria Cristofano, Flora Furente, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 48-48
Open Access | Times Cited: 3
Identification of serum metabolic traits of AIWG in first-episode schizophrenia patients
Suzhen Zhang, Zhaolin Zhai, Tianhao Gao, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models.
Robert A. Kozol, Julia E. Dallman
F1000Research (2023) Vol. 12, pp. 84-84
Open Access
Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)
Εleni Stamoula, Vasileios‐Periklis Stamatellos, Theofanis Vavilis, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 2, pp. 239-245
Closed Access
New Opportunities and Challenges of Early Psychosis
Marta Rapado‐Castro
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6531-6531
Open Access
Page 1

Scroll to top